WonderLab
Wonderlab
WonderLab is a Chinese new-nutrition brand that rode the post-2020 health-consciousness wave to become one of the period's standout consumer growth stories. It launched with meal-replacement shakes — hitting Tmall's top spot in that category within ten months of founding and clearing 60 million yuan in first-year sales — then expanded into probiotics, dietary fiber, and broader wellness products . The brand built its profile through aggressive, digitally native marketing: heavy WeChat Moments advertising, influencer campaigns across Weibo, Xiaohongshu and Douyin, and buzzy co-branding with the likes of HeyTea and SuperMonkey . Temasek came in as a strategic investor, as reported by investment media in 2021 . In FreeS Fund's reading, WonderLab exemplified how pandemic-era demand for at-home fitness solutions could translate into durable brand equity, provided a company could also handle supply-chain and inventory logistics under pressure .
AI-generated — may contain errors, please verify.
Coverage
Exclusive | Yungang Huang and Source Code's New VC: Back to Classic Playbook
Back to the classic VC playbook of "a pizza is all it takes."
暗涌Waves·What Will Humans Eat in the Future | FreeS Fund Report 27
The Future of Food Innovation
峰瑞资本·We Analyzed 1,000 LP Commitments and Found 30 Hidden Top Family Offices
They are also a microcosm of China's commercial evolution.
暗涌Waves·Biotech Firms Raise Nearly 4 Billion Yuan, Consumer Companies Land Over 1.4 Billion | FreeS Family Funding Roundup · August
We've also released three short videos this week — follow us to check them out.
峰瑞资本·FreeS Fund Wins Multiple Awards from Yicai, CBNData, 21st Century Business Herald, and Xiaofeijie; Hiring Investors and Interns | FreeS Weekly Vol.8
Welcome to the team.
峰瑞资本·Building a Brand Is Starting to Look Like Building an App — What Can Consumer Brands Learn From Super Apps About Growth? | FreeS Research
Five Brand Strategies for the New Media Era
峰瑞资本·Our Past 100 Days: Sailing Against the Wind, Growing Toward the Sun
Venture Capital's Pandemic Fight: A Chronicle
峰瑞资本·






